SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
Vaccines
FDA Vaccine Advisors To Meet for COVID-19 Vaccine Updates
The independent experts will meet on May 22 to discuss updates to the COVID-19 vaccine for the upcoming season.
May 8, 2025
 · 
2 min read
 · 
Tristan Manalac
FDA
Vinay Prasad’s FDA Appointment ‘Anything but Status Quo’
The UCSF professor and frequent YouTube poster has criticized COVID-19 vaccine mandates as well as the accelerated approval pathway and other FDA practices. Predictions of what his tenure might achieve are scattershot.
May 8, 2025
 · 
4 min read
 · 
Dan Samorodnitsky
Hands protect to stop rectangle block dominos with others rectangle standing. Risk and crisis management concept.
Cancer
C4 Therapeutics Shelves BRAF Blocker, Goes All-In on Multiple Myeloma Drug
The Massachusetts biotech will focus its efforts and resources into cemsidomide, an oral drug candidate being trialed for multiple myeloma and non-Hodgkin lymphoma.
May 7, 2025
 · 
1 min read
 · 
Tristan Manalac
Hiring collage showing HR checking applicant information
Job Trends
Hiring Outlook: Biopharma Job Market Yet To Surge, but Layoffs Decline
Although the job market did not pick up in April, layoffs were down year over year and month over month, according to BioSpace tallies. Meanwhile, Amgen, Novartis, Regeneron and Roche announced U.S. manufacturing investments that are sparking job creation.
May 7, 2025
 · 
3 min read
 · 
Angela Gabriel
Unvaccinated And vaccinated people as anti-vaxxer or individuals that oppose taking the vaccine with 3D illustration elements.
Vaccines
Is the New HHS Vaccine Requirement Anti-Vaccine Activism Disguised as Policy?
Yes, according to leading vaccine physician Paul Offit, who denounced the new placebo-controlled trial requirements for vaccines and sought greater clarity: “I don’t know what they’re talking about.”
May 7, 2025
 · 
6 min read
 · 
Heather McKenzie
Computational Biology - The Study of Biological Systems Through Computational Techniques and Modeling - Conceptual Illustration
Gene therapy
CRISPR’s Casgevy on the Rise With More Gene Therapy Proof of Concept To Come in 2025
CRISPR Therapeutics’ partner Vertex reported that more than 65 treatment centers have been activated for the gene therapy Casgevy. While Vertex handles the market, CRISPR has been focused on its clinical program.
May 7, 2025
 · 
4 min read
 · 
Annalee Armstrong
Novo Nordisk's logo on the facade of its building in Germany
Earnings
Novo Vows Smoother Market Waters for Wegovy—but Analysts Are Skeptical
The FDA in February formally declared the end of the semaglutide shortage, which Novo Nordisk expects will help improve the market position of Wegovy. But Eli Lilly’s Zepbound is quickly gaining ground, with sales just $300 million behind Wegovy in Q1.
May 7, 2025
 · 
2 min read
 · 
Tristan Manalac
Weeks Bridge of Harvard University
Job Trends
Recent Federal Actions Put US, Massachusetts Biotech Leadership at Risk: MassBio
MassBio’s new report outlines several concerns, including NIH cuts undermining the research engine, FDA reductions delaying innovation and trade barriers disrupting supply chains.
May 7, 2025
 · 
3 min read
 · 
Angela Gabriel
3d rendering of a plastic jar with medical pills on a hand truck on blue background. Medicine and health. Bottles and containers. Healthcare industry.
Manufacturing
Amid Trump’s Trade War, Some Drugmakers Stockpile Products in U.S.
Imports of pharmaceutical products surged in March, most of which came from Ireland, historically one of the biggest exporters of medicines to the U.S.
May 7, 2025
 · 
2 min read
 · 
Tristan Manalac
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS